Showing results (381-390 of 650) with videos related to

Sort By:
Pageof 65
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|June 6, 2003
Equation-of-state measurements of polyimide at pressures up to 5.8 TPa using low-density foam with laser-driven shock wavesK Takamatsu, N Ozaki, K A Tanaka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)M Tahara, N Kiyota, T Yokota, et al.
ESMO Open|May 13, 2021
Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI studyE Oki, J Watanabe, T Sato, et al.
American Journal of Human Genetics|October 10, 2001
Nonsense and frameshift mutations in ZFHX1B, encoding Smad-interacting protein 1, cause a complex developmental disorder with a great variety of clinical featuresK Yamada, Y Yamada, N Nomura, et al.
Nano Letters|September 30, 2016
Thermally Assisted Nonvolatile Memory in Monolayer MoS2 TransistorsG He, H Ramamoorthy, C-P Kwan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207LF Hirai, T Yamanaka, K Taguchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2018
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patientsK Shitara, T Yamanaka, T Denda, et al.
ESMO Open|November 8, 2025
Association between adjuvant chemotherapy and outcomes in resected locoregional recurrence of hormone receptor-positive HER2-negative breast cancer: a multi-institutional retrospective studyY Ozaki, E Tokuda, Y Sagara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2016
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE studyK Suzuki, T Yamanaka, H Hashimoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2020
Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trialK Yamazaki, T Yamanaka, M Shiozawa, et al.
Pageof 65